Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

1737 ARTÍCULOS , VIENDO DEL 1141 AL 1155

Transcranial direct current stimulation on primary sensorimotor area has no effect in patients with drug-naïve restless legs syndrome: a proof-of-concept clinical trial

Koo YS, Kim SM, Lee C, Lee BU, Moon YJ, Cho YW, Im CH, Choi JW, Kim KH, Jung KY.

Sleep Med. 2015 Feb;16(2):280-7. doi: 10.1016/j.sleep.2014.07.032. Epub 2014 Dec 2.

[Headache and sleep disorders]

Miyamoto M, Suzuki K, Miyamoto T, Hirata K.

Rinsho Shinkeigaku. 2014;54(12):991-3. doi: 10.5692/clinicalneurol.54.991.

Restless leg syndrome: a neglected diagnosis

Einollahi B, Izadianmehr N.

Nephrourol Mon. 2014 Sep 5;6(5):e22009. doi: 10.5812/numonthly.22009. eCollection 2014 Sep.

Sleep disorders: A review of the interface between restless legs syndrome and iron metabolism

Daubian-Nosé P, Frank MK, Esteves AM.

Sleep Sci. 2014 Dec;7(4):234-7. doi: 10.1016/j.slsci.2014.10.002. Epub 2014 Oct 30.

Pharmacokinetics, safety and tolerability of rotigotine transdermal patch in healthy Japanese and Caucasian subjects

Cawello W, Kim SR, Braun M, Elshoff JP, Ikeda J, Funaki T.

Clin Drug Investig. 2014 Feb;34(2):95-105. doi: 10.1007/s40261-013-0150-5.

Restless legs syndrome in Parkinson's disease

Rijsman RM, Schoolderman LF, Rundervoort RS, Louter M.

Parkinsonism Relat Disord. 2014 Jan;20 Suppl 1:S5-9. doi: 10.1016/S1353-8020(13)70004-X.

Treatment of the sleep disorders associated with Parkinson's disease

Trotti LM, Bliwise DL.

Neurotherapeutics. 2014 Jan;11(1):68-77. doi: 10.1007/s13311-013-0236-z.

Implications of nocturnal symptoms towards the early diagnosis of Parkinson's disease

Slow EJ, Postuma RB, Lang AE.

J Neural Transm (Vienna). 2014 Aug;121 Suppl 1:S49-57. doi: 10.1007/s00702-014-1168-4. Epub 2014 Feb 6.

Effects of gabapentin enacarbil on restless legs syndrome and leg pain in dementia with Lewy bodies

Fujishiro H.

Psychogeriatrics. 2014 Jun;14(2):132-4. doi: 10.1111/psyg.12043. Epub 2014 Feb 16.

Rating scales and questionnaires for assessment of sleep disorders in Parkinson's disease: what they inform about?

Zea-Sevilla MA, Martínez-Martín P.

J Neural Transm (Vienna). 2014 Aug;121 Suppl 1:S33-40. doi: 10.1007/s00702-014-1217-z. Epub 2014 Apr 23.

Microsubthalamotomy improves sleep in patients affected by advanced Parkinson's disease

Merlino G, Lettieri C, Mondani M, Belgrado E, Devigili G, Mucchiut M, Rinaldo S, Craighero C, D'Auria S, Skrap M, Eleopra R.

Sleep Med. 2014 Jun;15(6):637-41. doi: 10.1016/j.sleep.2013.12.016. Epub 2014 Feb 28.

Sleep disorders in Parkinson's disease

Schrempf W, Brandt MD, Storch A, Reichmann H.

J Parkinsons Dis. 2014;4(2):211-21. doi: 10.3233/JPD-130301.

Diagnosis, comorbidities, and management of restless legs syndrome

Becker PM, Novak M.

Curr Med Res Opin. 2014 Aug;30(8):1441-60. doi: 10.1185/03007995.2014.918029. Epub 2014 May 9.

Rotigotine transdermal system: developing continuous dopaminergic delivery to treat Parkinson's disease and restless legs syndrome

Benitez A, Edens H, Fishman J, Moran K, Asgharnejad M.

Ann N Y Acad Sci. 2014 Nov;1329:45-66. doi: 10.1111/nyas.12508. Epub 2014 Aug 21.

Rotigotine: the first new chemical entity for transdermal drug delivery

McAfee DA, Hadgraft J, Lane ME.

Eur J Pharm Biopharm. 2014 Nov;88(3):586-93. doi: 10.1016/j.ejpb.2014.08.007. Epub 2014 Aug 27.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias